Iryna Ananevych
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Iryna Ananevych has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Halyna Yurakh
Ivano-Frankivsk National Medical University, Ivano-Frankivsk, Ukraine
1 shared publication - Liliya Sobol
Ivano-Frankivsk National Medical University, Ivano-Frankivsk, Ukraine
1 shared publication - Mykhailo Pastukh
Ivano-Frankivsk National Medical University, Ivano-Frankivsk, Ukraine
1 shared publication - Omelian Yurakh
Ivano-Frankivsk National Medical University, Ivano-Frankivsk, Ukraine
1 shared publication - Romania Barchuk
Ivano-Frankivsk National Medical University, Ivano-Frankivsk, Ukraine
1 shared publication - Vasyl Pertsovich
Івано-Франківський національний медичний університет
1 shared publication
Latest Publications
- Open Access
- 1 October 2025
- Published by Ivano-Frankivsk National Medical University in Galician Medical Journal
- Vol. 32 (4)
Cardiovascular Morphological Changes in Metabolic and Endocrine Disorders: A Narrative Review
Metabolic and endocrine disorders profoundly influence cardiovascular morphology through complex mechanisms that converge on endothelial dysfunction. This review synthesises current evidence on structural alterations of the endocardium and arterial system under conditions such as hypertension, diabetes mellitus, metabolic syndrome, and hypothyroidism. Particular attention is given to the endothelium as an active regulator of vascular tone, haemostasis, inflammatory balance, and extracellular matrix dynamics. Chronic metabolic stress, oxidative injury, and dysregulated hormonal signalling drive endothelial-to-mesenchymal transition, smooth muscle cell phenotypic switching, collagen accumulation, and loss of vascular compliance. These processes underlie arterial wall thickening, microvascular rarefaction, endomyocardial fibrosis, and maladaptive myocardial remodelling. Distinct morphological patterns are highlighted across metabolic and endocrine states, including myxedematous changes in hypothyroidism, interstitial fibrosis in diabetes, and hypertrophic vascular remodelling in hypertension. By integrating histological, ultrastructural, and pathogenetic data, this narrative review underscores endothelial dysfunction as a unifying mechanism linking systemic disturbances to cardiovascular pathology. Recognition of these pathways not only advances morphofunctional understanding but also identifies early diagnostic markers and therapeutic targets in cardiometabolic disease.
- 1 October 2025
- Published by Ivano-Frankivsk National Medical University in Galician Medical Journal
- Vol. 32 (4)
Open AccessCardiovascular Morphological Changes in Metabolic and Endocrine Disorders: A Narrative Review
Metabolic and endocrine disorders profoundly influence cardiovascular morphology through complex mechanisms that converge on endothelial dysfunction. This review synthesises current evidence on structural alterations of the endocardium and arterial system under conditions such as hypertension, diabetes mellitus, metabolic syndrome, and hypothyroidism. Particular attention is given to the endothelium as an active regulator of vascular tone, haemostasis, inflammatory balance, and extracellular matrix dynamics. Chronic metabolic stress, oxidative injury, and dysregulated hormonal signalling drive endothelial-to-mesenchymal transition, smooth muscle cell phenotypic switching, collagen accumulation, and loss of vascular compliance. These processes underlie arterial wall thickening, microvascular rarefaction, endomyocardial fibrosis, and maladaptive myocardial remodelling. Distinct morphological patterns are highlighted across metabolic and endocrine states, including myxedematous changes in hypothyroidism, interstitial fibrosis in diabetes, and hypertrophic vascular remodelling in hypertension. By integrating histological, ultrastructural, and pathogenetic data, this narrative review underscores endothelial dysfunction as a unifying mechanism linking systemic disturbances to cardiovascular pathology. Recognition of these pathways not only advances morphofunctional understanding but also identifies early diagnostic markers and therapeutic targets in cardiometabolic disease.